- Ranibizumab in macular oedema secondary to branch retinal vein occlusion - 24 months of treatment2019 | Publication without faculty affiliation
- Surgical decompresion of branch retinal vein occlusionPublication without faculty affiliation
- Surgical treatment options of branch retinal vein occlusionPublication without faculty affiliation
- Surgical decompression of branch retinal vein occlusion complicated by macular edema ( a preliminary report of three cases)Publication without faculty affiliation
- Results of the first 12 months treatment of macular edema complicating brvo in patients treated with ranibizumab2018 | Third Faculty of Medicine
- Early Experience with the Surgical Decompression of the Vein in the BranchRetinal Occlusion2001 | First Faculty of Medicine
- Two-year follow-up results of patients with macular oedema due to retinal vein occlusion treated with ranibizumab2017 | First Faculty of Medicine
- Retinal vein occlusion2016 | Faculty of Medicine in Hradec Králové
- Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion2010 | Faculty of Medicine in Hradec Králové
- Correlation Between Ischemic Index of Retinal Vein Occlusion and Oxygen Saturation in Retinal Vessels2018 | Faculty of Medicine in Hradec Králové, Central Library of Charles University